Traduction de «support from pfizer to » (Français → Néerlandais) :

Pour consulter les détails sur l’aide financière octroyée aux organisations de patients internationales et européennes, cliquez ici pour 2008, 2009, 2010, 2011 et pour 2012. For detailed information on support from Pfizer to international and European-level patient groups, please click here for 2008, 2009, 2010, 2011 and for 2012.
Voor gedetailleerde informatie over de financiële bijdragen verleend aan internationale en Europese patiëntenorganisaties, klik hier voor 2008, 2009, 2010, 2011 en 2012.

Pfizer collabore depuis 2001 avec The AIDS Support Organisation (TASO) afin de proposer une réponse à l'absence de centres d'aide et de soins destinés aux patients souffrant du VIH-sida en Ouganda.
Pfizer werkt sinds 2001 samen met The AIDS Support Organisation (TASO) om een antwoord te bieden aan het gebrek aan hulp- en verzorgingscentra voor hiv- en aidspatiënten in Uganda.

Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties related to the acquisition of King by Pfizer that could cause results to differ from expectations include: uncertainties as to the timing of the merger; the possibility that a governmental entity may prohibit or delay the consummation of the merger; and the risk of shareholder litigation, including the disposition of currently pending litigation, in connection with the merger.
Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties.

“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis.
“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis. “We are proud to be a part of this innovative effort to support a healthier world”.

Excepté tel qu'expressément susmentionné, vous ne pouvez en aucun cas copier, afficher, télécharger, diffuser, modifier, reproduire, republier ou retransmettre les informations, textes ou documents, quels qu'ils soient, hébergés sur ce site Web ou une partie d'entre eux sur un support électronique quelconque ou au format papier, ni créer de travaux dérivés basés sur ces images, textes ou documents, sans le consentement explicite écrit de Pfizer.
De inhoud van de website mag vervolgens niet opnieuw worden gekopieerd, gereproduceerd of op een andere manier verder verspreid worden. Behalve in de omstandigheden die hierboven uitdrukkelijk zijn voorzien, mag u zonder de uitdrukkelijke schriftelijke toestemming van Pfizer geen enkele informatie, tekst of document uit deze website en geen enkel onderdeel ervan in om het even welk elektronisch medium of in hard copy kopiëren, tonen, downloaden, verspreiden, wijzigen, reproduceren, herpubliceren of opnieuw doorzenden, noch om het even welk afgeleid werk creëren dat gebaseerd is op deze beelden, teksten of documenten.

For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several
For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials.1 Effective strategies for the secondary prevention of stroke include

Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 191C (D/2012/10.273/88) Available from: [http ...]
Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 191C (D/2012/10.273/88) Available from: [http ...]

Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 185C (D/2012/10.273/61) Available from: [http ...]
Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. KCE Reports 185C (D/2012/10.273/61) Available from: [http ...]